Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Having Applied for IPO to HKEX, What to Expect on Advaccine R&D Pipelines beyond COVID-19 DNA Vaccine

PharmaSources/YefenghongAugust 06, 2021

Tag: COVID-19 DNA Vaccine , R&D Pipelines , new respiratory syncytial virus (RSV)

Download PSI
PharmaSources Customer Service